New Advances in the Lung Cancer Continuum: From Lung Cancer Screening to Diagnosis and Treatment

View Webinar Recording: CLICK HERE

Lung cancer remains the leading cause of cancer death in America. While the overall 5-year survival rate of lung cancer has improved to 21.7%, this survival rate improves to 59% when lung cancer is detected early. Unfortunately, only 23% of all lung cancers are detected early.

Join local lung health experts as they discuss the need to optimize lung cancer screening, diagnosis and treatment. This webinar will provide an update on lung cancer screening, including the new USPSTF lung cancer guidelines, define new technologies to diagnose lung cancer earlier and determine optimal strategies to guide lung nodule management.

Date: Wednesday, October 6th
Time: 5:30pm - 7:00pm CST (90 Minutes)
Cost: Free
View Webinar: CLICK HERE

Webinar Agenda

Introduction
Moderator: Dr. Sangeeta Bhorade (Veracyte)
Medical Director, Interstitial Lung Disease, Veracyte, Inc.
Board Member, American Lung Association

What’s New: Lung cancer screening, the latest diagnostic biomarkers and robotic bronchoscopy
Speaker: Neeraj R. Desai, MD, MBA ,FCCP, FACP, D-AABIP
Medical Director, AMITA Health Pulmonary Endoscopy and Interventional Pulmonology
Associate Professor of Medicine, UI Health
Board Member, American Lung Association

Minimally Invasive Thoracoscopic Surgery for Lung Cancer: VATS to Robotic Surgery
Speaker: Jessica Donington, MD, MSCR
Professor of Surgery; Chief, Section of Thoracic Surgery, UChicago Medicine

Lung Cancer Therapy: Optimizing Outcomes
Speaker: Jyoti Patel, MD
Medical Director of Thoracic Oncology, Northwestern Medicine
Assistant Director for Clinical Research, Lurie Cancer Center
Associate Vice-Chair for Clinical Research, Department of Medicine

Q & A

Please reach out to Erik Maranto at EventsCHI@Lung.org with any questions.

Local Sponsors